🟢 Edesa Biotech is trading 6.6% up today on momentum from recent financing and Phase 3 data

Edesa Biotech is trading 6.6% up in after-hours trading at $7.26, rebounding from its regular-session close of $6.81.

• The move follows continued positive sentiment from a recent $3.5 million PIPE financing led by the company's CEO and healthcare-focused investors.
• Shares remain supported by previously highlighted Phase 3 data for the paridiprubart program, which has driven gains in recent sessions.
• No new company-specific headlines or earnings releases were reported late on July 13, 2026.